Unite ‘deeply disappointed’ as pharmaceutical giant plans to axe
380 jobs in Essex
10th February 2010
Plans by pharmaceutical giant Glaxo Smith Kline (GSK) to make
about 380 employees redundant in Harlow have been condemned by
Unite, the largest union in the country.
A third of the workforce is due to lose their jobs after
projects for pain relief, anxiety and depression drugs end at the
Essex plant.
Unite was also critical that the axe was falling just a week
after the company announced a 12 per cent jump in profits.
Unite regional officer, Geoff Usher, said: ”We are deeply
disappointed by the news of the redundancies which will be a body
blow to the local economy. Unite will be doing its utmost to assist
our members at this difficult time for them and their families.
”We will be having talks with the company to see if alternative
employment can be found within GSK for the employees affected. The
redundancies come as GSK has again made healthy profits which those
who are losing their jobs have contributed to.
‘”It is therefore puzzling that those who have helped create a
very profitable company should now be seeking new employment.”
ENDS
Email to a friend
